About Novitium Pharma
Novitium Pharma is a company based in East Windsor (United States) founded in 2016 by Muthusamy Shanmugam was acquired by ANI Pharmaceuticals in March 2021. The company has 111 employees as of October 31, 2024.
- Headquarter East Windsor, United States
- Employees 111 as on 31 Oct, 2024
- Founders Muthusamy Shanmugam
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$1.16 M (USD)74as on Mar 31, 2022
-
Net Profit
$129.47 K (USD)188as on Mar 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
111
as on Oct 31, 2024
-
Acquired by
ANI Pharmaceuticals
(Mar 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Novitium Pharma
Detailed funding history for Novitium Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Novitium Pharma
Novitium Pharma has secured backing from 1 investor. Prominent investors backing the company include ANI Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
Locked | Locked | Locked |
Investor details for Novitium Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novitium Pharma
Investment portfolio details for Novitium Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novitium Pharma
Detailed financials for Novitium Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novitium Pharma Comparisons
Peer comparison for Novitium Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novitium Pharma
Detailed competitors of Novitium Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novitium Pharma
Complete news archive for Novitium Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novitium Pharma
Novitium Pharma was founded in 2016.
Novitium Pharma is headquartered in East Windsor, United States. It is registered at East Windsor, New Jersey, United States.
As of Oct 31, 2024, the latest employee count at Novitium Pharma is 111.
Annual revenue of Novitium Pharma is $1.16M as on Mar 31, 2022.
Novitium Pharma was founded in 2016 in East Windsor, United States, within the pharmaceutical sector. Generic prescription medications are developed, manufactured, and distributed by the company, with emphasis on various therapeutic categories and dosage forms. Operations are supported by a team of scientists and engineers, covering research, production, and market delivery while adhering to quality standards for safety and efficacy.
Novitium Pharma has 1 investor. Key investors include ANI Pharmaceuticals.